Journal
CLINICAL KIDNEY JOURNAL
Volume 14, Issue -, Pages 16-22Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ckj/sfab167
Keywords
CKD; CKD-aP; ESRD; itch; pruritus; uremic pruritus
Categories
Ask authors/readers for more resources
CKD-aP is a highly prevalent and distressing condition impacting dialysis and nondialysis patients, yet there are limited treatment options and guidelines available. This review evaluated current management and treatment options, including emerging therapies, and proposed new guidelines for managing patients with CKD-aP.
Chronic kidney disease (CKD)-associated pruritus (CKD-aP) is an underdiagnosed yet severely distressing condition that impacts 60% of patients on dialysis and many nondialysis patients with Stages 3-5 CKD. However, despite its high prevalence, there are currently limited treatment options available for these patients and a lack of treatment guidelines for clinicians. In this manuscript, we reviewed the available literature in order to evaluate the current management and treatment options for CKD-aP, including dialysis management, topical treatments, gabapentinoids, opioids and alternative medicine. We also review the available data on CKD-aP treatments in development and propose new guidelines for managing patients with CKD-aP.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available